DEVELOPMENT AND CHARACTERIZATION OF ORODISPERSIBLE TABLETS OF PROPRANOLOL HYDROCHLORIDE USING CALCIUM CROSS-LINKED CASSIA FISTULA GUM AND CROSS CARMELLOSE SODIUM

  • KULJIT SINGH IKG Punjab Technical University, Jalandhar-Kapurthala Highway, Kapurthala Punjab, India 144603
  • SHAILESH SHARMA Pharmaceutical Research Division, Department of Pharmaceutics, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, BELA (Ropar) Punjab India 140111

Abstract

Objective: The present investigation was aimed towards developing calcium crosslinked derivative of carboxymethylated cassia fistula gum and crosscarmellose sodium based orodispersible tablets (ODTs) of propranolol hydrochloride for enhancing the bioavailability and efficacy.


Methods: Orodispersible tablets (ODTs) of propranolol hydrochloride was formulated using natural (a carboxymethylated derivative of cassia fistula gum) and synthetic polymer (crosscarmellose sodium) by wet and dry granulation, lyophilization and cotton candy methods and then finally compressed by direct compression. The prepared ODTs were evaluated for several parameters such as hardness, friability, in vitro disintegration time, in vitro drug release. In vivo and stability studies were carried out on optimized formulation coding PC1.


Results: Drug polymer interaction were judged by FT-IR, DSC and XRD. The optimized formulation coding PC1 prepared by cotton candy process containing 2.5% w/w of crosslinked cassia fistula gum has the least disintegration time (18.9±0.4s), weeting time (12.5±0.8s) and relased the drug of 88.2% within 10 min in contrast to croscarmellose sodium. In vivo absorption studies revealed that same formulation has Cmax (µg/ml) 2.13±0.73, tmax (h) 0.21±0.17 and (µg ml-1 h-1) 14.33±1.59.


Conclusion: This research manuscript clearly shows the successful development of the ODTs loaded with an antihypertensive drug, namely propranolol hydrochloride. The formulation developed by cotton candy process utilizing crosslinked cassia fistula gum as a natural superdisintegrant in contrast to other existing techniques can be a best option over synthetic superdisintegrant i.e. crosscarmellose sodium. The prepared ODTs was enhanced the absorption rate by lowering tmax, which inturn enhance the bioavailability and the efficacy of drug.

Keywords: Hypertension, Croscarmellose sodium, Crosslinked cassia fistula gum, Lyophilization, Cotton candy method, Bioavailability

References

1. Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, et al. The optimal choice of medication administration route regarding intravenous, intramuscular and subcutaneous injection. Paitent Prefer Adherence 2015;9:923-42.
2. Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics 2019;11:129.
3. Fallingborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull 1999;46:183-96.
4. Gupta H, Bhandari D, Sharma A. Recent trends in oral drug delivery: a review. Recent Pat Drug Delivery Formulation 2009;3:162-73.
5. Masih A, Kumar A, Singh S, Tiwari AK. Fast dissolving tablets: a review. Int J Curr Pharm Res 2017;9:8-18.
6. Killedar SG, Nale AB, More HN, Nadaf SJ, Pawar AA, Tamboli US. Isolation, characterization and evaluation of cassia fistula linn. seed and pulp polymer for pharmaceutical application. Int J Pharm Investig 2014;4:215-25.
7. Rai PR, Tiwary AK, Rana V. Superior disintegrating properties of calcium cross-linked cassia fistula gum derivatives for fast dissolving tablets. Carbohyd Polym 2012a;87:1098–104.
8. Singh SK, Singh S. Evaluation of cassia fistula linn. seed mucilage in tablet formulations. Int J Pharmtech Res 2010;2:1839-46.
9. Goyal P, Kumar V, Sharma P. Carboxymethylation of tamarind kernel powder. Carbohyd Polym 2007;69:251-5.
10. Dave V, Yadav RB, Ahuja R, Yadav S. Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques. Bull Faculty Pharm 2017;55:31–9.
11. Shoukri RA, Ahmed IS, Shamma RN. In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets. Eur J Pharm Biopharm 2009;73:162–71.
12. Battist GE, Fuisz RC, Myers GL. Process and apparatus for making rapidly dissolving dosage units and product therefrom. European Patent Office: EP0764019A4; 1995.
13. Panda S, Hematalha N, Shankar PU, Baratan SR. Formulation and evaluation of orodispersible tablets (ODTs) of diclofenac sodium by using superdisintegrant from aatural origin. Int J Appl Pharm 2019;11:190-7.
14. Thulluru A, Kumar VS, MKP BR. Effect of effervescene in combination with superdisintegrants in the formulation of propranolol hydrochloride oral disintegrating tablets. Asian J Pharm Clin Res 2017;10:227-34.
15. Prakash GA, Bhagavansing RR. Formulation and evaluation of taste mask orally dispersible paracetamol tablet. J Drug Delivery 2016;6:30-6.
16. Sheshala R, Khan N, Chitneni M, Darwis Y. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants. Arch Pharm Res 2011;34:1945-56.
17. ZT Chowhan. Moisture, hardness, disintegration and dissolution interrealationships in compressed tablets prepared by the wet granulation process. Drug Dev Ind Pharm 1979;5:41-62.
18. Iqbal Z, Babar A, Ashraf M. Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method. Drug Dev Ind Pharm 2002;28:129-34.
19. Mandal S, Basu SK, Sa B. Sustained release of a water-soluble drug from alginate matrix tablets prepared by wet granulation method. AAPS PharmSciTech 2009;10:1348-56.
20. Shah M, Patel D. Design and evaluation of fast dissolving tablet containg tadalafil solid dispersion. J Crit Rev 2020;7:579-82.
21. Dattatraya MS, Pooja SA, Parag DK, Avish DM. Formulation and in vitro evaluation of fast dissolving tablet of verapamil hydrochloride. Int J Pharm Sci 2018;10:93-9.
22. Kuralla H, Saripilli R, Venkata R. Prepration and evaluation of orally disintegrating tablets of drotarverine hydrochloride using sublimation technique. Int J Pharm Sci 2018;10:85-95.
23. Patel BP, Patel JK, Rajput GC, Thakor RS. Formulation and evaluation of mouth dissolving tablets of cinnarizine. Indian J Pharm Sci 2010;72:522–5.
24. Krishnaraj K, Chandrasekar MJ, Nanjan MJ, Muralidharan S, Manikandan D. Development of sustained release antipsychotic tablets using novel polysaccharide isolated from delonix regia seeds and its pharmacokinetic studies. Saudi Pharm J 2012;20:239-48.
25. Sarfraz R, Khan H, Mahmood A, Ahmad M, Maheen S, Sher M. Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin. Indian J Pharm Sci 2015;77:83-90.
26. Anroop BN, Shery J. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharma 2016;7:27-31.
27. Kim YI, Fluckiger L, Hoffman M, Lartaud Idjouadiene I, Atkinson J, Maincent P. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats. Br J Pharmacol 1997;120:399-404.
28. Wiederhold NP. Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections. Clin Pharmacol 2015;23:1-8.
29. Huang MZ, Chen JC, Hu XJ, Liu J, Wu GL, Zhou HL, et al. Comparative bioavailability and pharmacokinetics of sirolimus tablets in healthy chinese volunteers. Int J Clin Pharmacol Ther 2013;51:816-22.
30. Raoof AA, Chiu P, Ramtoola Z, Cumming IK, Teng C, Weinbach SP, et al. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J Pharm Sci 2004;93:1431-9.
31. Saravanakumar M, Raja B. Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats. Eur J Pharmacol 2011;5:87-94.
32. Sung JH, Jo YS, Kim SJ, Ryu JS, Kim MC, Ko HJ, et al. Effect of lutein on L-NAME-induced hypertensive rats. Korean J Physiol Pharmacol 2013;17:339-45.
33. Patil GB, Patil ND, Deshmukh PK, Patil PO, Bari SB. Nanostructured lipid carriers as a potential vehicle for carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol 2016;44:12-9.
34. Nayak AK, Pal D. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology. Int J Biol Macromol 2011;49:784-93.
35. Huanbutta K, Sittikijyothin W. Use of seed gums from tamarindus indica and cassia fistula as controlled-release agents. Asian J Pharm Sci 2018;13:398–408.
36. Singh R, Maity S, Sa B. Effect of ionic crosslink on the release of metronidazole from partially carboxymethylated guar gum tablet. Carbohyd Polym 2014;106:414-21.
37. Brus J Brus. ©. UNESCO/IUPAC Course NMR Spectroscopy of Polymers; 2005.
38. Thotakura N, Dadarwal M, Kumar P, Sharma G, Guru SK, Bhushan S, et al. Chitosan-stearic acid based polymeric micelles for the effective delivery of tamoxifen: cytotoxic and pharmacokinetic evaluation. AAPS PharmSciTech 2017;18:759-68.
39. Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech 2008;9:250-8.
Statistics
118 Views | 82 Downloads
Citatons
How to Cite
SINGH, K., & SHARMA, S. (2020). DEVELOPMENT AND CHARACTERIZATION OF ORODISPERSIBLE TABLETS OF PROPRANOLOL HYDROCHLORIDE USING CALCIUM CROSS-LINKED CASSIA FISTULA GUM AND CROSS CARMELLOSE SODIUM. International Journal of Applied Pharmaceutics, 12(4), 160-169. https://doi.org/10.22159/ijap.2020v12i4.37955
Section
Original Article(s)